We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 5.00 | 1.74% | 293.00 | 292.50 | 293.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 294.00 | 285.50 | 290.00 | 114,100 | 16:21:29 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medicinal Chems,botanicl Pds | 89.54M | -184.16M | -1.7380 | -1.69 | 305.17M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 03/3/2025 | 09:00 | UK RNS | Oxford Biomedica PLC Total Voting Rights |
| 26/2/2025 | 07:00 | UK RNS | Oxford Biomedica PLC OXB to present at Leerink Conference |
| 20/2/2025 | 15:42 | UK RNS | Oxford Biomedica PLC Holding(s) in Company |
| 20/2/2025 | 13:32 | UK RNS | Oxford Biomedica PLC OXB Lentiviral Vectors Used in Gene Therapy Trial |
| 20/2/2025 | 13:13 | UK RNS | Oxford Biomedica PLC Standard form for notification of major holdings |
| 17/2/2025 | 11:34 | ALNC |  Oxford BioMedica shares fall as revenue to stay below 2022 level |
| 17/2/2025 | 07:00 | UK RNS | Oxford Biomedica PLC Full Year Trading Update and Notice of Results |
| 05/2/2025 | 07:00 | UK RNS | Oxford Biomedica PLC Appointment of New Joint Corporate Broker |
| 03/2/2025 | 07:00 | UK RNS | Oxford Biomedica PLC Total Voting Rights |
| 23/1/2025 | 11:07 | UK RNS | Oxford Biomedica PLC Block Listing Application |
1 Year Oxford Biomedica Chart |
Intraday Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
